Pfizer begins testing use of pnuemococcal vaccine together with COVID-19 booster shot By Reuters
© Reuters. FILE PHOTO: An individual walks previous a Pfizer emblem amid the coronavirus illness (COVID-19) pandemic within the Manhattan borough of New York Metropolis, New York, U.S., April 1, 2021. REUTERS/Carlo Allegri/File Photograph
(Reuters) – Pfizer Inc (NYSE:) mentioned on Monday it has began immunizing the primary sufferers in a brand new research taking a look at administering the corporate’s 20-valent pneumococcal conjugate vaccine candidate following a booster dose of the Pfizer-BioNTech COVID-19 shot.
The research will embrace 600 adults over 65 years who will probably be recruited from the late-stage research of the Pfizer-BioNTech COVID-19 vaccine, and could have acquired their second dose of the vaccine at the least six months previous to getting into the co-administration research, the corporate mentioned.
Fusion Media or anybody concerned with Fusion Media is not going to settle for any legal responsibility for loss or injury because of reliance on the knowledge together with knowledge, quotes, charts and purchase/promote alerts contained inside this web site. Please be totally knowledgeable relating to the dangers and prices related to buying and selling the monetary markets, it is likely one of the riskiest funding types attainable.
3 Upgraded Stocks to Buy With the Market Approaching New Highs By StockNews
© Reuters. 3 Upgraded Stocks to Buy With the Market Approaching New Highs The stock market is once again trying…
Denmark stocks lower at close of trade; OMX Copenhagen 20 down 0.74% By Investing.com
© Reuters. Denmark stocks lower at close of trade; OMX Copenhagen 20 down 0.74% Investing.com – Denmark stocks were lower…